Florida declares emergency on Atlantic coast as Hurricane Isaias approaches

By Zachary Fagenson and Nathan Layne

MIAMI (Reuters) – Florida Governor Ron DeSantis declared a state of emergency for counties on the Atlantic coast with Hurricane Isaias expected to hit the state as early as Friday night, a development that prompted the widespread closure of COVID-19 testing sites.

The hurricane, packing maximum sustained winds of 75 miles (120.7 km) per hour, is currently lashing the southeastern part of the Bahamas and the Turks and Caicos Islands, the U.S. National Hurricane Center (NHC) said on its Twitter feed.

The NHC said heavy rains may begin to affect South and east-Central Florida beginning late Friday night, and the eastern Carolinas by early next week, potentially causing flooding in low-lying and poorly drained areas.

DeSantis told a news conference that he signed an executive order establishing a state of emergency for east coast counties stretching from Miami-Dade in the south to Nassau at the northern tip, a move that makes it easier to mobilize resources.

“While current projections have the eye of Isaias remaining at sea the situation remains fluid and can change quickly,” the governor said. “I want Floridians to know that the state of Florida is fully prepared for this.”

Miami-Dade’s public beaches, parks, marinas, and golf courses were set to close on Friday as Isaias strengthened to a Category 1 hurricane and forecasters predicted it would reach Category 2, with winds as powerful as 110 miles per hour.

Miami-Dade County officials have also closed drive-through and walk-up testing sites for COVID-19, following a similar move by Broward County Mayor Dale V.C. Holness, who said the sites could reopen on Wednesday after the storm had passed.

“We have thousands of tests that will not be conducted until we get these test sites up and running again,” Miami-Dade County Mayor Carlos Gimenez said in a news conference on Friday.

For weeks Florida has been at the epicenter of the U.S. coronavirus outbreak – it reported a record one-day increase in COVID-19 deaths for a third consecutive day on Thursday -although reports of new cases have recently slowed in the state.

DeSantis said COVID-19 testing sites would remain open on Florida’s west coast and that testing at hospitals and community centers may also continue. The storm’s main impact would be to sites set up outside and vulnerable to the wind, he said.

At full capacity, Florida had 162 test sites in all but two of its 67 counties.

The governor also said he planned to issue new guidance on testing to narrow its scope. He estimated that currently about half of the people who were being tested were either “curious” without symptoms or people looking to go back to work.

DeSantis said the state’s department of health, based on recently issued guidance from the U.S. Centers for Disease Control and Prevention, would now suggest that employers focus on symptomatic people, rather than screening all workers.

(Reporting by Nathan Layne in Wilton, Connecticut; Editing by Nick Zieminski, Jonathan Oatis, David Gregorio and Paul Simao)

Hurricane Isaias heads toward Florida with 75-mph winds – Hurricane Center

By Zachary Fagenson

MIAMI (Reuters) – Heavy rains from Hurricane Isaias could hit Florida late Friday night before the powerful storm moves up the East Coast into early next week, the U.S. National Hurricane Center (NHC) warned, prompting the closure of COVID-19 testing sites.

The hurricane, packing maximum sustained winds of 75 miles (120.7 km) per hour, is currently lashing the southeastern part of the Bahamas and the Turks and Caicos Islands, the Miami-based forecaster posted on its Twitter feed on Friday.

“Heavy rains associated with Isaias may begin to affect south and east-Central Florida beginning late Friday night, and the eastern Carolinas by early next week, potentially resulting in isolated flash and urban flooding, especially in low-lying and poorly drained areas” the NHC said on its website.

Miami-Dade County officials closed drive-through and walk-up testing sites for COVID-19. Public beaches, parks, marinas, and golf courses were also set to close on Friday as Isaias strengthened to a Category 1 hurricane and forecasters predicted it would reach Category 2.

Broward County Mayor Dale V.C. Holness had on Thursday also announced testing sites would close, with plans to reopen on Wednesday morning.

As of Friday morning the storm was predicted to most impact Florida’s central, eastern region before moving north.

At full capacity Florida had 162 test sites in all but two of the state’s 67 counties. Some counties will continue testing through their individual health departments.

“We have thousands of tests that will not be conducted until we get these test sites up and running again,” Miami-Dade County Mayor Carlos Gimenez said in a virtual news conference on Friday morning.

(Reporting by Nathan Layne in Wilton, Connecticut; Editing by Nick Zieminski and Jonathan Oatis)

Coronavirus child care pinch in U.S. poses threat to economic gains of working women

By Jonnelle Marte and Rachel Dissell

CLEVELAND (Reuters) – Most days, Zora Pannell works from her dining room table, sitting in front of her computer, turning off the video on Zoom calls to nurse her one-year-old daughter, Savannah.

Pannell has balanced working from home and caring for her daughter and son Timothy, aged 2, since March when she started a new job as a manager for a language services company the same week that Ohio issued a “stay at home” order to stop the spread of the coronavirus.

Working from home is an exhausting daily juggle but she’s more worried about being told it’s time to return to the office. Her husband cannot watch the children during the day because he has a job at a local steel mill and the couple have been unable to find a daycare center they deemed safe and affordable close to their Shaker Heights apartment on the eastern fringe of Cleveland.

“I’ve already felt penalized for being a working mother,” said Pannell, 30, who is worried she would have to quit if she is not allowed to keep working from home. “Now it’s like I’m in purgatory.”

The pandemic upended child care plans for many parents in the United States, forcing them – particularly mothers – to grapple with tough choices that are only becoming more difficult as states push return-to-work policies to try to revive the battered economy.

Do they hunt for expensive and hard-to-find child care that could expose their families to COVID-19, which is still raging across much of the country? Or do they scale back on work, or even quit, threatening their financial stability?

The barriers risk stalling or reversing the economic gains of recent years made by working women, who are more likely to take a career hit than men when they are unable to find child care, studies show.

A survey by Northeastern University between May 10-June 22 found that 13% of working parents had to resign or reduce their work hours because of a lack of child care during the health crisis, with women impacted significantly more than men. In all, of those who said they had lost a job due to child care problems, 60% were women, the survey found.

“If women don’t have child care, they can’t go back to work,” said Karen Schulman, Child Care and Early Learning Research Director for the National Women’s Law Center. If that doesn’t happen, “you end up creating a system that is going to result in vast gender inequities”.

Prior to the pandemic, the labor force participation rate for women aged 25-54 touched 77% in February, rising from 73% in September 2015 and close to the peak reached in 2000, when the share of women in the labor force began to plateau, in part because of challenges accessing affordable child care, experts say.

LIMITED OPTIONS

Pressure looks certain to mount on families in the coming weeks, as various aid programs and protections that offered relief to jobless parents expire, including enhanced unemployment benefits, eviction moratoriums and a freeze on student loan payments.

“There’s this fragile, invisible thread holding the lives of our moms, holding the lives of our economy together,” said Chastity Lord, president and chief executive of the Jeremiah Program, a Minneapolis-based nonprofit organization that supports single mothers and their children.

Finding a way to broaden access to child care will be pivotal to helping the U.S. labor market heal from the economic devastation caused by the pandemic, with latest data showing the economy contracting an annualized 32.9% in the second quarter of 2020 and approximately one out of five workers claiming unemployment insurance in the week ending July 11.

Child care was already scarce before the coronavirus led to the shuttering of thousands of centers. More than half of all Americans lived in a child care “desert” as of 2018, defined by the Center for American Progress, a liberal nonprofit group in Washington, as an area with no licensed child care providers or less than one slot for every three children under five.

Now, in many states, care centers accept only limited numbers of children to prevent the virus from spreading. Additionally, families that relied on grandparents or other older relatives or neighbors must weigh up the risks of asking for their help again and perhaps exposing them to a disease that has proved especially deadly for the elderly.

Chantel Springer, 24, worked at Starbucks in Manhattan during the early months of the pandemic but has been on furlough since June, when the store cut back on staff to adjust to lower demand and social distancing requirements. Now that her unemployment benefits could shrink as low as $325 a week, Springer is making arrangements to get back to her job as a shift manager.

“I feel like I have to work,” said Springer, explaining that the reduced benefits would not be enough to cover the rent, food, diapers and other costs.

This month, Springer transferred to a store in Brooklyn so she could be closer to her apartment and her two-year-old. But finding someone to babysit her son is a challenge. Springer can no longer leave the toddler with her mother, who recently moved to take care of a disabled sister whose husband died from Covid-19. For now, she is looking to coordinate schedules with her son’s father, who has also returned to work at a retail store.

HOME ALONE

Under the CARES Act passed in late March, parents who lost access to child care because of the pandemic became eligible for unemployment benefits. But the process of qualifying for the program, which varies from state to state, became less clear cut as the school year ended and some day care centers began to re-open with limited capacity.

The Labor Department sought to clarify with guidance that parents should resort to their typical summer child care plans.

Many states, including New York, Missouri and Louisiana, allow parents to self-certify each week, under penalty of perjury, that their child care center was closed and that they met the requirements to continue receiving benefits. Other states, like California and Texas, make such decisions on a “case-by-case” basis.

While child care places are hard to find for toddlers, they are even scarcer for school-age children and many summer programs for this age-group went online, leaving parents facing a quandary.

Sarah Sapp is hatching plans to rig up an old cell phone for her 11-year-old son, Avery.

The 37-year-old waitress from North Olmsted, a western suburb of Cleveland, fears her son, who sometimes struggles to pay attention to instructions, isn’t quite mature enough to be left home alone while she serves food and drinks at a high-end tavern. But she feels she has little choice.

When Ohio initially ordered restaurants and bars to close in March, Sapp qualified for state unemployment. But when the state told people it was safe to return to work in May, she was informed that she would no longer be eligible. Sapp tried to sign her son up for a day camp at her local recreation center but it got canceled.

More problems are piling up on the horizon. Sapp’s school district has told parents they must choose between all online lessons or a hybrid of two days shortened days in school and three days at home when classes resume in September. Neither of these options would allow her to work her lunchtime shift.

“I feel stuck,” Sapp said. “There doesn’t seem to be a right choice no matter how I look at things.”

(Rachel Dissell is a contributing reporter with The Fuller Project, a global nonprofit newsroom reporting on issues that impact women.; Jonnelle Marte reported for this story from New York; Editing by Heather Timmons and Crispian Balmer)

Large U.S. COVID-19 vaccine trials will exclude pregnant women for now

By Julie Steenhuysen

CHICAGO (Reuters) – The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters.

Moderna and Pfizer, which has partnered with Germany’s BioNTech, this week separately launched clinical trials that use a new and unproven gene-based technology. Both companies are requiring proof of a negative pregnancy test and a commitment to using birth control from women of childbearing age who enroll.

Drugmakers say they first need to make sure the vaccines are safe and effective more generally. In addition, U.S. regulators require that drugmakers conduct safety studies in pregnant animals before the vaccines are tested in pregnant women to ensure they don’t harm the fetus or lead to miscarriage.

Bioethicists, vaccine and maternal health experts have argued for years that pregnant women should be included early in trials of pandemic vaccines so they would not need to wait until long after a successful candidate emerges. That debate fell on deaf ears in recent outbreaks of Ebola and Zika, but has taken on new urgency in the era of COVID-19, as studies show pregnant women are at increased risk of severe disease from the new coronavirus.

“It’s a problem because if (vaccines) are not tested in pregnancy, then they may not be available or people may not be comfortable offering them,” said Dr. Denise Jamieson, chief of gynecology and obstetrics for Emory Healthcare in Atlanta.

According to the 2012 Census, 75.4 million U.S. women were of childbearing age, defined as 15 to 50 years old. Currently, pregnant women are recommended to take flu and whooping cough vaccines and certain others depending on individual circumstances, but none of these have been specifically tested and proven safe for pregnant women.

“We have an enormous number of women of childbearing age and potentially getting pregnant, and what’s the safest vaccine for them?” said Dr. Larry Corey, a vaccine expert at Fred Hutchinson Cancer Center in Seattle who is helping oversee vaccine trials conducted by Moderna and other drugmakers in collaboration with the U.S. government.

Doctors may want to see even more data for completely new vaccine technologies, such as those used by Moderna and Pfizer, compared with one that has already been used in pregnant women.

Such differences highlight why “we need multiple vaccines” to best address the needs of specific populations, Corey said.

A PRECEDENT IN PREGNANCY

Johnson & Johnson, which kicked off a small-scale safety trial for its COVID-19 vaccine this week, is using the same underlying technology that it used with its Ebola vaccine, which has been used in 1,000 pregnant women in Democratic Republic of Congo. Larger studies with that vaccine are now under way.

J&J’s chief scientific officer, Dr. Paul Stoffels, told Reuters the company has done many years of “extensive” pre-clinical study with the Ebola vaccine, including on pregnant animals, and “has not see any challenges.”

Stoffels said J&J would decide in the next few weeks whether it will include pregnant women in its large Phase 3 late-stage trial for a COVID-19 vaccine due to start in September. Pfizer expects to start toxicology studies in pregnant animals shortly, with data ready for review by the U.S. Food and Drug Administration in the first quarter of 2021. Studies in pregnant women could start some time afterward.

“We continue to explore potential ways to shorten the time to studies in pregnant women,” Dr. Bill Gruber, Pfizer’s senior vice president of vaccine clinical research and development, told Reuters.

Of course, unplanned pregnancies can happen even when women are using reliable contraception. Based on past experiences in such trials, Gruber said he expects about 1% of women in Pfizer’s Phase 3 trial, or about 150 women, will become pregnant. And those women and their babies will be followed closely.

Moderna said in an emailed statement that the company launched its safety study in pregnant animals at the end of June and expects results by the end of this year.

“Once we have generated additional safety data for our vaccine, and importantly demonstrated that it is efficacious, we intend to conduct additional studies in this important population,” a Moderna spokesperson said.

Sanofi, whose coronavirus vaccine is based on its flu vaccine platform, is doing reproductive toxicology in animals, but those results won’t be ready before the start of the company’s large Phase 3 trials, expected to start by year-end.

Sanofi may establish a pregnancy registry after the vaccine is approved to track outcomes in pregnant women, as has been done in the past.

Merck & Co. said it has not made any decisions yet on when to test its vaccine candidate in pregnant women. Novavax and AstraZeneca Plc declined to comment on their plans.

Dr. Flor Munoz, an expert in maternal use of vaccines at Baylor College of Medicine, said companies have been reluctant to test anything in pregnant women since the 1950’s and 60’s, after the drug thalidomide, which was used to treat nausea in pregnancy, caused widespread birth defects. She agrees that preliminary testing is needed.

The vaccines “need to be reasonably safe and reasonably effective,” she said. “We don’t necessarily have to finish the Phase 3 trials.”

(Reporting by Julie Steenhuysen; editing by Michele Gershberg and Leslie Adler)

U.S. COVID-19 aid bill talks ongoing as jobless benefit nears end

By Susan Heavey

WASHINGTON (Reuters) – Negotiations over another coronavirus relief bill continue, the No. 2 Democrat in the U.S. House of Representatives said as a federal jobless benefit was set to expire on Friday with no sign of a deal between the White House and Democrats.

“We’re going to be negotiating every minute that is possible,” despite the Republican-led Senate’s adjournment for the weekend, House Majority Leader Steny Hoyer told MSNBC in an interview.

Lawmakers and the White House are at odds over efforts to further shore up the economy and manage the novel coronavirus pandemic that has left tens of millions of Americans out of work and killed at least 152,384 people in the United States.

In a meeting on Thursday night between top White House officials and congressional Democratic leaders, negotiations focused on an extension of the expiring unemployment benefit.

Senate Majority Leader Mitch McConnell sent senators home for the weekend without reaching a deal to extend the extra $600 per week unemployment benefits many received amid the outbreak.

According to a person familiar with the closed-door negotiations, the White House proposed reducing the $600 weekly payment to $400 for the next four months. While that was a move toward the demands of House Speaker Nancy Pelosi and Senate Democratic Leader Chuck Schumer, the source said they rejected it as insufficient.

On Thursday, Senate Republicans tried, without success, to pass a bill reducing the jobless benefit to $200 per week.

For weeks, McConnell has said that any deal with Democrats would require a shield for companies and schools from liability lawsuits as they reopen during the pandemic.

The source, who asked not to be identified, said the White House hinted that it could embrace a deal without that provision.

Besides the $600 “enhanced” payment, Democrats are seeking a wide-ranging economic stimulus bill that would include about $1 trillion in aid to state and local governments experiencing plunging revenues during the economic downturn.

In mid-May, the Democratic-controlled House passed a $3 trillion bill that the Republican Senate has ignored.

“We’re here, we’re on the phone. We will be negotiating with those who want to get to a reasonable place,” Hoyer told MSNBC.

More details on the White House position may emerge when Trump’s spokeswoman Kayleigh McEnany gives a news briefing scheduled for 10:30 a.m. EDT (1430 GMT). Pelosi is also scheduled to talk to reporters at 10:45 a.m. (1445 GMT).

There is no ‘zero risk’ in easing travel restrictions, WHO says

By Bhargav Acharya and Kanishka Singh

(Reuters) – There is no “zero risk” strategy for countries easing international travel restrictions during the COVID-19 pandemic, and essential travel for emergencies should remain the priority, the World Health Organization (WHO) said.

In a long-awaited update to its guidance on travel, the United Nations global health agency said cross-border trips for emergencies, humanitarian work, the transfer of essential personnel and repatriation would constitute essential travel.

“There is no ‘zero risk’ when considering the potential importation or exportation of cases in the context of international travel,” it said in the updated guidance posted on its website on Thursday.

A surge of new infections in many parts of the world has prompted some countries to reintroduce some travel restrictions, including testing and quarantining incoming passengers.

The WHO had said in June it would update its travel guidelines before the northern hemisphere summer holidays.

The WHO’s guidance can be used by governments and industries to help shape policies, but is not enforceable.

The updated travel advice is little changed from previous guidance, which also included infection control advice applicable to other settings such as social distancing, wearing masks, washing hands and avoiding touching the face.

The WHO urged each country to conduct its own risk-benefit analysis before lifting any or all travel restrictions. Authorities should take into account local epidemiology and transmission patterns, it said, as well as national health and social distancing measures already in place.

Countries that choose to quarantine all travelers on arrival should do so after assessing the risks and consider local circumstances, the WHO said.

“Countries should continuously plan for and assess their surge capacities for testing, tracking, isolating and managing imported cases and quarantine of contacts,” it said.

The WHO said this week that international travel bans cannot stay in place indefinitely, and countries will have to do more to reduce the spread of the novel coronavirus within their borders.

(Reporting by Bhargav Acharya and Kanishka Singh in Bengaluru; Writing by Kate Kelland, editing by Diane Craft, Marguerita Choy, Grant McCool and Timothy Heritage))

Fauci to testify before U.S. House COVID-19 panel after being blocked by White House

By David Morgan

WASHINGTON (Reuters) – Dr. Anthony Fauci, the top U.S. infectious disease expert, will testify on Friday before a coronavirus subcommittee in Congress, weeks after President Donald Trump’s administration first refused to let him address the panel.

Fauci’s testimony comes at the end of a week when the pandemic’s tragic toll on the country has become far clearer. The United States on Wednesday experienced its 150,000th death from the disease — more than any other country — and data on Thursday showing a deep economic plunge.

Democrats said the Trump administration initially prevented Fauci from testifying to the panel by saying he was unavailable for the entire month of July and relented only after House Majority Whip James Clyburn wrote to Vice President Mike Pence.

A veteran of six Republican and Democratic administrations, Fauci has become the most familiar face of the administration’s coronavirus task force.

This week, Trump, who has often bristled against scientists’ advice on responding to the pandemic, bemoaned the degree to which Fauci is admired, saying “nobody likes me. It can only be my personality.”

U.S. Centers for Disease Control and Prevention Director Dr. Robert Redfield and Admiral Brett Giroir, assistant secretary at the Department of Health and Human Services, are also scheduled to testify before the Select Subcommittee on the Coronavirus Crisis.

Headed by Clyburn, the subcommittee was created this year to monitor the trillions of dollars approved by Congress to help the United States weather the health and economic impacts of the COVID-19 pandemic.

Earlier this week, Trump retweeted a post accusing Fauci and Democrats of suppressing the use of the drug hydroxychloroquine to treat the new coronavirus that included a link to a video of a group discounting the need for face masks amid the pandemic. The tweet was removed by social media companies.

(Reporting by David Morgan; Editing by Scott Malone and David Gregorio)

U.S. records nearly 25,000 coronavirus deaths in July

By Christine Chan and Lisa Shumaker

(Reuters) – U.S. coronavirus deaths rose by almost 25,000 in July and cases doubled in at least 18 states during the month, according to a Reuters tally, dealing a crushing blow to hopes of quickly reopening the economy.

The United States has recorded nearly 1.8 million new cases in July out of its total 4.5 million infections, an increase of 66% with many states yet to report on Friday. Deaths in July rose at least 19% to over 152,000 total.

The biggest increases were in Florida, with over 300,000 new cases in July, followed by California and Texas with about 250,000 each. Those three states also saw cases double in June.

Cases also more than doubled in Alabama, Alaska, Arizona, Georgia, Hawaii, Idaho, Mississippi, Missouri, Montana, Nevada, Oklahoma, Oregon, South Carolina, Tennessee and West Virginia, according to the tally.

Connecticut, Massachusetts, New Jersey, New York had the lowest increases, with cases rising 7% or less.

The United States shattered single day global records in July by reporting over 77,000 new cases on July 16. During the month, 33 out of 50 states had one-day record increases in cases and 19 set records for how much deaths rose in 24 hours, according to a Reuters tally.

After a rapid acceleration in cases, the outbreak appears to be stabilizing in Arizona, Florida and Texas. Health officials are now concerned the outbreak has migrated to the Midwest from summer travel.

The news that more states could be hard hit by the virus comes a day after the U.S. gross domestic product collapsed at a 32.9% annualized rate last quarter, the nation’s worst economic performance since the Great Depression.

(Reporting by Christine Chan in New York and Lisa Shumaker in Chicago; Editing by Lincoln Feast.)

Deal on U.S. coronavirus aid bill elusive as jobless benefit nears expiration

By Susan Cornwell and Patricia Zengerle

WASHINGTON (Reuters) – Just one day before a federal jobless benefit was set to expire, the U.S. Congress was no closer on Thursday to a deal to extend or replace the extra $600-per-week in payments to tens of millions thrown out of work by the coronavirus pandemic.

Senate Republicans were discussing a way to hold a vote, possibly early next week, on just the unemployment benefit. But there were no signs that Democrats, who have been resisting such a narrow response, would go along.

With little prospect of having to be in Washington to vote on a coronavirus-response bill this week, the Senate was mulling beginning its weekend immediately and returning on Monday — after the unemployment insurance benefit has expired.

Democrats have been pushing for extending the jobless benefit as part of a $3 trillion coronavirus-aid bill the U.S. House of Representatives passed in March, while Republicans want $1 trillion overall. They have proposed a $200 weekly benefit, which would come in addition to state unemployment payments.

The past four days of private talks involving top White House and congressional officials have yielded no tangible results and much of Thursday was spent with Republicans and Democrats criticizing each other.

“Republicans don’t want this aid to expire,” said Senate Majority Leader Mitch McConnell. “But the Speaker and the Democratic Leader say they won’t agree to anything unless the program pays people more to stay home than to work,” he added.

He was referring to House Speaker Nancy Pelosi and Senate Democratic Leader Chuck Schumer.

Schumer answered back, saying a “skinny bill” floated by the White House to provide reduced unemployment benefits did not have the votes to pass the House or the Senate. “It’s a stunt.”

Treasury Secretary Steven Mnuchin and White House Chief of Staff Mark Meadows have been meeting with Democratic leaders over how best to help the country recover from the COVID-19 pandemic.

Besides the $600-per-week supplemental unemployment benefit expiring Friday, a federal moratorium that prevented housing evictions ended last week, leaving untold numbers of Americans at risk of losing their homes.

Congress has already passed aid packages totaling $3 trillion to alleviate the effects of the virus, which has killed 150,000 Americans.

Republicans oppose a Democratic call for nearly $1 trillion to aid state and local governments, while Democrats reject a Republican plan to prevent liability lawsuits for businesses and schools as they reopen during the pandemic.

Some Republicans, such as Senator Mitt Romney, continued pushing for a stop-gap measure to prevent unemployed people from being left without any federal benefits that are on top of state aid.

“I do think that we need to have a temporary program that is put in place so we don’t have a gap in people’s receipts,” Romney told reporters.

Chinese-backed hackers targeted COVID-19 vaccine firm Moderna

By Christopher Bing and Marisa Taylor

WASHINGTON (Reuters) – Chinese government-linked hackers targeted biotech company Moderna Inc <MRNA.O>, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a U.S. security official tracking Chinese hacking activity.

Last week, the U.S. Justice Department made public an indictment of two Chinese nationals accused of spying on the United States, including three unnamed U.S.-based targets involved in medical research to fight the COVID-19 pandemic. The indictment states the Chinese hackers “conducted reconnaissance” against the computer network of a Massachusetts biotech firm known to be working on a coronavirus vaccine in January.

Moderna, which is based in Massachusetts and announced its COVID-19 vaccine candidate in January, confirmed to Reuters that the company had been in contact with the FBI and was made aware of the suspected “information reconnaissance activities” by the hacking group mentioned in last week’s indictment.

Reconnaissance activities can include a wide range of actions, including probing public websites for vulnerabilities to scouting out important accounts after entering a network, cybersecurity experts say.

“Moderna remains highly vigilant to potential cybersecurity threats, maintaining an internal team, external support services and good working relationships with outside authorities to continuously assess threats and protect our valuable information,” spokesman Ray Jordan said, declining to provide further detail.

The U.S. security official, who spoke on condition of anonymity, did not provide further details. The FBI and the U.S. Department of Health and Human Services declined to disclose the identities of companies targeted by Chinese hackers.

Moderna’s vaccine candidate is one of the earliest and biggest bets by the Trump administration to fight the pandemic. The federal government is supporting development of the company’s vaccine with nearly half a billion dollars and helping Moderna launch a clinical trial of up to 30,000 people beginning this month.

China is also racing to develop a vaccine, bringing together its state, military and private sectors to combat a disease that has killed over 660,000 people worldwide.

A July 7 indictment released last week alleges that the two Chinese hackers, Li Xiaoyu and Dong Jiazhi, conducted a decade-long hacking spree that most recently included the targeting of COVID-19 medical research groups.

Prosecutors said Li and Dong acted as contractors for China’s Ministry of State Security, a state intelligence agency. Messages left with several accounts registered under Li’s digital alias, oro0lxy, were not returned. Contact details for Dong were not available.

The Chinese Embassy in Washington referred Reuters to recent Chinese Foreign Ministry comments that said: “China has long been a major victim of cyber thefts and attacks” and its officials “firmly oppose and fight” such activities. The Chinese government has consistently denied any role in hacking incidents across the globe. The embassy spokesperson did not address specific questions sent via email.

The two other unnamed medical research companies mentioned in the Justice Department indictment are described as biotech companies based in California and Maryland. Prosecutors said the hackers “searched for vulnerabilities” and “conducted reconnaissance” against them.

The court filing describes the California firm as working on antiviral drug research and suggested the Maryland company had publicly announced efforts to develop a vaccine in January. Two companies that could match those descriptions: Gilead Sciences Inc <GILD.O> and Novavax Inc <NVAX.O>.

Gilead spokesperson Chris Ridley said the firm does not comment on cybersecurity matters. Novavax would not comment on specific cyber security activities but said: “Our cyber security team has been alerted to the alleged foreign threats identified in the news.”

A security consultant familiar with multiple hacking investigations involving premier biotech firms over the last year said Chinese hacking groups believed to be broadly associated with China’s Ministry of State security are one of the primary forces targeting COVID-19 research, globally. This matches the description of the indicted hackers, as MSS contractors.

(Reporting by Christopher Bing and Marisa Taylor; Editing by Chris Sanders and Lisa Shumaker)